Decreasing Long-term Opioid Use in Cancer Survivors
SuspendedNot applicableNCT05067556
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is a feasibility pilot trial assessing a behavioral intervention for chronic pain among disease-free cancer survivors to decrease long-term opioid dependence.
Study details
- Official title
- Creating a Pathway for Disease-Free Cancer Survivors to Decrease Long-term Opioid Use
- Conditions
- Pain
- Chronic Pain
- Cancer Pain
- Survivorship
- Interventions
- Behavioral: Acceptance and Commitment Therapy for chronic pain (ACT-CP)
- Sponsor
- Virginia Commonwealth University
- Start date
- 2021-12-20
- Primary completion
- 2028-03-30
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosis of cancer of any type, currently in remission, having completed active primary therapy. Patients on oral adjuvant hormone therapy will still be eligible. * Completed active therapy must have been curative in intent (for example stage IV cancer patients such as head and neck cancer patients treated with curative intent are eligible). * Self-reported cancer pain for \>= 3 months * Opioid use \>= 5MME/day (morphine milligram equivalents) as prescribed by physician for cancer-related pain for at least 6 months beyond completion of their cancer treatment * VCUHealth system patient Exclusion Criteria: * History of opioid use prior to cancer diagnosis * Anyone with prior history of substance use disorder or currently enrolled in a methadone program * Anyone with schizophrenia or bipolar disorder * Current utilization of psychotherapy services for pain, depression, anxiety, and/or PTSD * Cognitive concerns that would prevent meaningful engagement in treatment * Inability to converse in English * Lack of working telephone and Internet connection (must have at least one or the other) * Anyone found to have progression of cancer * Anyone diagnosed with cancer recurrence or new cancer during their study period * Documented diagnosis of or positive screen for current substance use disorder (score \>5 on the Drug Abuse Screening Test-10 \[DAST-10\]) * Anyone scoring \>=8 on ORT indicating very high risk for opioid abuse
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05067556